ESC Premium Access

SGLT2 inhibitors for the treatment of heart failure.

Congress Session

About the speaker

Professor Scott Solomon

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
43 presentations
0 follower

3 more presentations in this session

Old drugs in the modern era: ACEI/ARB, MRAs+digoxin.

Speaker: Professor M. Pfeffer (Boston, US)


New drugs on the horizon: sGC stimulators, myosin activators.

Speaker: Professor C. Lam (Singapore, SG)


Sacubitril/valsartan: opportunities and challenges.

Speaker: Professor J. McMurray (Glasgow, GB)


Access the full session

Pharmacological Treatment of Chronic Heart Failure

Speakers: Professor S. Solomon, Professor M. Pfeffer, Professor C. Lam, Professor J. McMurray

About the event


ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Related content

ESC Premium Access

A complete prescription for secondary prevention.

29 August 2021

Open Access

Classification of HF and diagnosis and treatment of HFmrEF and HFpEF.

27 August 2021

Open Access

New recommendations for the treatment of HFrEF.

27 August 2021

This platform is supported by

logo Novo Nordisk